Joel N. Gossner


Direct: 404.873.8648
Fax: 404.873.8649
171 17th Street NW
Suite 2100
Atlanta, Georgia 30363


Joel is a partner in the Corporate & Finance practice and a member of the Payments Systems & Fintech, Life Sciences, and Healthcare Private Equity industry teams.

He represents private and public companies, funds, and individuals in a wide variety of business matters, including mergers, acquisitions and dispositions (including distressed transactions), debt and equity financings, joint ventures, corporate governance, and commercial agreements. He has significant experience representing buyers and sellers in middle-market M&A transactions.

Joel works with clients in the distribution, technology, payments, manufacturing, healthcare, pharmaceutical, medical device, and restaurant industries, among others. He counsels both established enterprises and early-stage companies.

While in law school, Joel interned with the U.S. Securities and Exchange Commission, The Coca-Cola Company, and the Honorable Timothy C. Batten, Sr., United States District Judge for the Northern District of Georgia.


  • Represented one of the U.S.’s largest private companies in strategic merger and acquisition transactions, including advising its software business unit in its acquisition of a pharmacy management software company, and counseling its wholesale drug distribution business unit in its acquisitions of an independent pharmacy chain and a pharmaceutical distributor.

  • Represented a Fortune 500 company in strategic transactions throughout the U.S., including acquisitions in the e-commerce and distribution industries

  • Represented a closely held cleaning and sanitation products manufacturer in its sale to a Fortune 500 company

  • Represented a medical device start-up in its sale to a NYSE-listed purchaser

  • Represented an over-the-counter pharmaceutical company in its acquisition of a portfolio of commercial and pipeline products from a major pharmaceuticals company

  • Represented a manufacturer and packager of pharmaceuticals, over-the-counter drugs and dietary supplements in the negotiation of a supply agreement valued in excess of $100 million with a large, independent provider of over-the-counter products

  • Represented a restaurant chain owner/operator and a debtor-in-possession in a 363 sale to its “stalking horse” bidder

  • Represented early stage Internet-of-Things company in a Series Seed equity financing transaction and an early stage employee benefits company in a Series A financing transaction


  • Emory University School of Law, Juris Doctor,
    with Honors
    • Dean’s Awards for Outstanding Achievement in Contracts, Income Taxation, Trusts and Estates, and Constitutional Law
    • Emory Bankruptcy Developments Journal, Managing Editor
  • Tennessee Wesleyan College, Bachelor of Science in Business Administration in Accounting,
    summa cum laude
    • Accounting Award
    • Harry Russell Caldwell History Award
    • Sigma Tau Delta International English Honor Society
    • Rookie of the Year, Southeastern Lacrosse Conference, 2008
  • State of Georgia


  • Best Lawyers: Ones to Watch in America®, Banking and Finance Law, Corporate Law, 2021-24

News & Insights